These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 26408645)
1. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy. Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645 [TBL] [Abstract][Full Text] [Related]
2. Serum response factor provokes epithelial-mesenchymal transition in renal tubular epithelial cells of diabetic nephropathy. Zhao L; Chi L; Zhao J; Wang X; Chen Z; Meng L; Liu G; Guan G; Wang F Physiol Genomics; 2016 Aug; 48(8):580-8. PubMed ID: 27260841 [TBL] [Abstract][Full Text] [Related]
3. Serum response factor induces endothelial-mesenchymal transition in glomerular endothelial cells to aggravate proteinuria in diabetic nephropathy. Zhao L; Zhao J; Wang X; Chen Z; Peng K; Lu X; Meng L; Liu G; Guan G; Wang F Physiol Genomics; 2016 Oct; 48(10):711-718. PubMed ID: 27565710 [TBL] [Abstract][Full Text] [Related]
4. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy. Zhang M; Liu M; Xiong M; Gong J; Tan X J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431 [TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Li Y; Kang YS; Dai C; Kiss LP; Wen X; Liu Y Am J Pathol; 2008 Feb; 172(2):299-308. PubMed ID: 18202193 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo. Du M; Wang Q; Li W; Ma X; Wu L; Guo F; Zhao S; Huang F; Wang H; Qin G Biochem Biophys Res Commun; 2016 Mar; 471(4):416-22. PubMed ID: 26902117 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802 [TBL] [Abstract][Full Text] [Related]
8. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria. Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Wang S; Li Y; Zhao J; Zhang J; Huang Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166 [TBL] [Abstract][Full Text] [Related]
10. miR-124a enhances therapeutic effects of bone marrow stromal cells transplant on diabetic nephropathy-related epithelial-to-mesenchymal transition and fibrosis. Cai X; Wang L; Wang X; Hou F J Cell Biochem; 2020 Jan; 121(1):299-312. PubMed ID: 31190436 [TBL] [Abstract][Full Text] [Related]
11. Grem2 mediates podocyte apoptosis in high glucose milieu. Wen H; Kumar V; Mishra A; Song S; Aslam R; Hussain A; Wang H; Zhou X; He X; Wu G; Luo H; Lan X; Malhotra A; Singhal PC Biochimie; 2019 May; 160():113-121. PubMed ID: 30831151 [TBL] [Abstract][Full Text] [Related]
12. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes. Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417 [TBL] [Abstract][Full Text] [Related]
13. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition. Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats. Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907 [TBL] [Abstract][Full Text] [Related]
15. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805 [TBL] [Abstract][Full Text] [Related]
16. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease. Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829 [TBL] [Abstract][Full Text] [Related]
17. C-peptide ameliorates high glucose-induced podocyte dysfunction through the regulation of the Notch and TGF-β signaling pathways. Luo J; Jiang J; Huang H; Jiang F; Xu Z; Zhou Z; Zhu H Peptides; 2021 Aug; 142():170557. PubMed ID: 33901627 [TBL] [Abstract][Full Text] [Related]
18. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions. Lv Z; Hu M; Zhen J; Lin J; Wang Q; Wang R Int J Biochem Cell Biol; 2013 Feb; 45(2):255-64. PubMed ID: 23153508 [TBL] [Abstract][Full Text] [Related]
19. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo. Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065 [TBL] [Abstract][Full Text] [Related]
20. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759. Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]